- Home
- FBYD vs AQST Comparison
FBYD vs AQST Comparison
Compare FBYD & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBYD
- AQST
- Stock Information
- Founded
- FBYD 2021
- AQST 2004
- Country
- FBYD United States
- AQST United States
- Employees
- FBYD N/A
- AQST N/A
- Industry
- FBYD
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- FBYD
- AQST Health Care
- Exchange
- FBYD Nasdaq
- AQST Nasdaq
- Market Cap
- FBYD 255.4M
- AQST 272.9M
- IPO Year
- FBYD N/A
- AQST 2018
- Fundamental
- Price
- FBYD $5.81
- AQST $3.31
- Analyst Decision
- FBYD
- AQST Strong Buy
- Analyst Count
- FBYD 0
- AQST 6
- Target Price
- FBYD N/A
- AQST $10.67
- AVG Volume (30 Days)
- FBYD 26.6K
- AQST 1.6M
- Earning Date
- FBYD 08-12-2025
- AQST 08-05-2025
- Dividend Yield
- FBYD N/A
- AQST N/A
- EPS Growth
- FBYD N/A
- AQST N/A
- EPS
- FBYD N/A
- AQST N/A
- Revenue
- FBYD $6,937,000.00
- AQST $54,228,000.00
- Revenue This Year
- FBYD N/A
- AQST N/A
- Revenue Next Year
- FBYD N/A
- AQST $45.71
- P/E Ratio
- FBYD $369.95
- AQST N/A
- Revenue Growth
- FBYD N/A
- AQST 5.29
- 52 Week Low
- FBYD $3.62
- AQST $2.12
- 52 Week High
- FBYD $13.25
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- FBYD 43.96
- AQST 54.11
- Support Level
- FBYD $4.81
- AQST $3.13
- Resistance Level
- FBYD $6.77
- AQST $3.46
- Average True Range (ATR)
- FBYD 0.79
- AQST 0.24
- MACD
- FBYD 0.02
- AQST -0.04
- Stochastic Oscillator
- FBYD 38.59
- AQST 17.52
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.